Dose-dependent and disease-modifying effects of striatal infusion of cholesterol in Huntington's disease
Birolini, G.; Valenza, M.; DiPaolo, E.; Vezzoli, E.; Talpo, F.; Maniezzi, C.; Caccia, C.; Leoni, V.; Bocchi, V. D.; Conforti, P.; Sogne, E.; Petricca, L.; Cariulo, C.; Verani, M.; Caricasole, A.; Falqui, A.; Biella, G.; Cattaneo, E.
Show abstract
A variety of pathophysiological mechanisms are implicated in Huntingtons disease (HD). Among them, reduced cholesterol biosynthesis has been detected in the HD mouse brain from pre-symptomatic stages, leading to diminished cholesterol synthesis, particularly in the striatum. In addition, systemic injection of cholesterol-loaded brain-permeable nanoparticles ameliorates synaptic and cognitive function in a transgenic mouse model of HD. To identify an appropriate treatment regimen and gain mechanistic insights into the beneficial activity of exogenous cholesterol in the HD brain, we employed osmotic mini-pumps to infuse three escalating doses of cholesterol directly into the striatum of HD mice in a continuous and rate-controlled manner. All tested doses prevented cognitive decline, while amelioration of disease-related motor defects was dose-dependent. In parallel, we found morphological and functional recovery of synaptic transmission involving both excitatory and inhibitory synapses of striatal medium spiny neurons. The treatment also enhanced endogenous cholesterol biosynthesis and clearance of mutant Huntingtin aggregates. These results indicate that cholesterol infusion to the striatum can exert a dose-dependent, disease-modifying effect and may be therapeutically relevant in HD.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impaired Functional Connectivity of Cortico-Amygdala Pathway Can Drive Social Behavior Deficits in Synucleinopathies 95%
- Defects in AMPAR trafficking and microglia activation underlie socio-cognitive deficits associated to decreased expression of Phosphodiesterase 2A 95%
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43. 95%
Similar papers in this journal
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease 96%
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 95%
- Diabetic phenotype in mouse and humans with β-amyloid pathology reduces the number of microglia around β-amyloid plaques 95%
Similar papers in this journal
- Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival 96%
- Pathway-specific deregulation of striatal excitatory synapses in LRRK2 mutations 95%
- Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice. 95%
Similar papers in this journal
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates 97%
- VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's disease neurons 96%
- Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines 96%
Similar papers in this journal
- SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration 96%
- Age-dependent regulation of axoglial interactions and behavior by oligodendrocyte AnkyrinG 96%
- Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.